Patent ID: 7375123
Filing Date: 2008-05-20
Classification: A61K,A61P,A61Q,C07D

Abstract:
1. A method of treating a disorder mediated by a melanocortin receptor selected from the group consisting of obesity, impaired oral glucoase tolerance, elevated blood glucose levels, type II diabetes, Syndrome X, diabetic retinopathy, acute neurodegenerative disorders, chronic neurodegenerative disorders, plexopathies, male erectile dysfunction, dry eyes, acne, dry skin, aged skin, seborrheic dermatitis, rosacea, excessive ear wax, meibornian gland disorder, pseudofolliculitis, yeast infections, dandruff, hiradenitis suppurativa, ocular rosacea and eccrine gland disorder comprising administering to a subject in need thereof a therapeutically effective amount of a compound of formula (II) wherein R R R and pharmaceutically acceptable salts thereof.